Masimo has announced that the iSpO2 Rx pulse oximeter for Android and iOS devices has received CE Mark clearance for medical use in select countries, offering clinicians the power of Masimo SET Measure-through Motion and Low Perfusion pulse oximetry on their smart phones and tablets.
iSpO2 Rx, available outside the US, provides accurate spot-check and short-term assessment of oxygen saturation (SpO2), pulse rate (PR), and perfusion index (PI). iSpO2 Rx is ideal for emergency clinicians, traveling respiratory therapists and physicians, chronic obstructive pulmonary disease patients, and asthmatics.
Compact and intuitive operation with a familiar touch-screen interface, iSpO2 Rx comes with an integrated finger pulse oximetry sensor or an optional M-LNCS connector, which allows the iSpO2 Rx to be used with more than 20 Masimo SET pulse oximetry sensors.
iSpO2 Rx utilizes the same Masimo SET Measure-through Motion and Low Perfusion pulse oximetry technology. Masimo SET pulse oximetry has been shown to help clinicians reduce ventilator weaning time and arterial blood gas measurements in the ICU, and save lives and costs while reducing rapid response activations and ICU transfers on the general floor.
iSpO2 Rx for select Android devices and iPad, iPhone, and iPod touch, also features a downloadable and upgradeable iSpO2 Rx App, ensuring clinicians have the latest mobile medical technologies at their fingertips at all times.
iSpO2 Rx, with real-time display of pleth waveform with signal IQ for low measurement confidence, can store and email up to 12 hours of measurement history in a global standard . iSpO2 Rx with the M-LNCS connector is compatible with Masimo adhesive and reusable sensors for pediatric and adult use.